These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3487928)

  • 1. Adenosine deaminase deficiency and chondro-osseous dysplasia.
    Wortmann RL; Veum JA; Cheung HS
    Adv Exp Med Biol; 1986; 195 Pt A():81-3. PubMed ID: 3487928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
    Wortmann RL; Veum JA; Ryan LM; Cheung HS
    Arthritis Rheum; 1989 Aug; 32(8):1014-21. PubMed ID: 2788422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.
    Ratech H; Greco MA; Gallo G; Rimoin DL; Kamino H; Hirschhorn R
    Am J Pathol; 1985 Jul; 120(1):157-69. PubMed ID: 4014441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
    Cederbaum SD; Kaitila I; Rimoin DL; Stiehm ER
    J Pediatr; 1976 Nov; 89(5):737-42. PubMed ID: 978320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 6. Basis for the chondro-osseous dysplasia associated with adenosine deaminase deficiency: selective toxicity to immature chondrocytes.
    Wortmann RL; Tekkanat KK; Veum JA; Meyer RA; Hood JO; Horton WA
    Adv Exp Med Biol; 1991; 309B():265-8. PubMed ID: 1781380
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

  • 8. Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency.
    Simmonds HA; Levinsky RJ; Perrett D; Webster DR
    Biochem Pharmacol; 1982 Mar; 31(6):947-51. PubMed ID: 7082375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
    Raivio KO; Schwartz AL; Stern RC; Polmar SH
    Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal diagnosis for adenosine deaminase deficiency.
    Ziegler JB; Van der Weyden MB; Lee CH; Daniel A
    J Med Genet; 1981 Apr; 18(2):154-6. PubMed ID: 7241535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency.
    Levinsky RJ; Davies EG; Simmonds HA; Webster DR; Adinolfi M
    Adv Exp Med Biol; 1984; 165 Pt A():33-8. PubMed ID: 6609527
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of adenosine deaminase deficiency in the mutant mouse wasted.
    Geiger JD; Nagy JI
    FEBS Lett; 1986 Nov; 208(2):431-4. PubMed ID: 3780980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
    Adrian GS; Hutton JJ
    J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
    Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ
    Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.